Ultraviolet Radiation and Malignant Melanoma
Essential features of the epidemiology and photobiology of cutaneous malignant melanoma (CMM) in Norway were studied in comparison with data from countries at lower latitudes. Arguments for and against a relationship between ultraviolet radiation (UV) from sun and sun beds are discussed. Our data indicate that UV is a carcinogen for CMM and that intermittent exposures are notably melanomagenic. This hypothesis was supported both by latitude gradients, by time trends and by changing patterns of tumor density on different body localizations. However, even though UV radiation generates CMM, it may also have a protective action and/or an action that improves prognosis. The same may be true for a number of internal cancers.
There appears to be no, or even an inverse latitude gradient for CMM arising on non-UV exposed body localizations (uveal melanoma). Furthermore, CMM prognosis was gradually improved over all years of increasing incidence (up to 1990), but during the last 10 to 15 years, incidence rates decreased and prognosis was not further improved.
While CMM incidence rates are twice as high in South Norway as in North Norway, the ratios of death rates to incidence rates are higher in the North, where the annual UV fluences are lower. Death- and incidence rates in Australia and New Zealand fully support this.
Comparisons of skin cancer data from Norway and Australia/New Zealand indicate that squamous cell carcinoma and basal cell carcinoma are mainly related to annual solar UVB fluences, while UVA fluences play a larger role for CMM.
KeywordsSkin Cancer Ultraviolet Radiation Basal Cell Carcinoma Cutaneous maUgnant Melanoma Uveal Melanoma
Unable to display preview. Download preview PDF.
- 2.Moan J, Dahlback A. Ultraviolet radiation and skin cancer: epidemiological data from Scandinavia. In: Young AR, Bjørn LO, Moan J, Nultsch W, eds. Environmental UV Photobiology. New York/London: Plenum Press; 1993:255–93.Google Scholar
- 4.Elwood JM, Whitehead SM, Gallagher RP. Epidemiology of human malignant skin tumours with special reference to natural and artificial ultraviolet radiation exposure. In: Conti CJ, Slaga TJ, Klein-Szanto AJP, eds. Skin tumors: experimental and clinical aspects. New York: Raven Press; 1989:55–84.Google Scholar
- 6.Green A, Williams G. Ultraviolet radiation and skin cancer: epidemiological data from Australia. In: Young AR, Bjørn LO, Moan J, Nultsch W, eds. Environmental UV photobiology. New York/London: Plenum Press: 1993, 233–54.Google Scholar
- 10.Moan J, Dahlback A. Predictions of health consequences of a changing UV-fluence. In: Dubertret L, Santus R, Morliere P, eds. Ozone, sun, cancer. Paris: Les Editions Inserm, 1995:87–100.Google Scholar
- 11.Weinstock MA. Ultraviolet radiation and skin cancer: epidemiological data from the United States and Canada. In: Young AR, Bjørn LO, Moan J, Nultsch W, eds. Environmental UV photobiology. New York/London: Plenum Press, 1993:295–344.Google Scholar
- 13.AICR. Globocan 2002 database. Available online at http://www-dep.iarc.fr/ (Accessed on February 2007).Google Scholar
- 21.Dahlback A, Stamnes K. A new spherical model for computing the radiation field available for photolysis and heating rate at twilight. Planet Space Sci 1991; 671–683.Google Scholar
- 22.Stamnes K, Tsay SC, Wiscombe W et al. Numerically stable algorithm for discrete-ordinate-method for radiative transfer in multiple scattering and emitting layered media. Appl Opt 1988; 2502–2509.Google Scholar
- 23.McKinlay AF, Diffey AL. A reference action spectrum for ultraviolet induced erythema in human skin. CIE J 1987; 6:17–22.Google Scholar
- 25.Porojnicu AC, Robsahm TE, Dahlback A et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role? Lung Cancer 2005 DOI: 10.1016/j lungcan 2006.11.013.Google Scholar
- 26.Moan J, Porojnicu AC, Dahlback A. Epidemiology of cutaneous malignant melanoma. In: Ringborg U, Brandberg Y, Breitbart EW, Greinert R, eds. Skin cancer prevention. New York: Informa Healthcare; 2006:179–201.Google Scholar
- 30.Sigmundsdottir H, Pan J, Debes GF et al. DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 2007. DOI: 10.1038/ni 1433.Google Scholar
- 31.Yu GP, Hu DN, McCormick SA. Latitude and Incidence of Ocular Melanoma. Photochem Photobiol 2006.Google Scholar
- 40.de V E, Bray FI, Coebergh JW et al. Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003; 20;107:119–126.Google Scholar
- 41.De Vries E, Tyczynski JE, Parkin DM. Cutaneous malignant melanoma in Europe. ENCR Cancer fact sheets 4. 2003; France, European network of cancer registries.Google Scholar
- 42.Lund CC, Browder NC. The estimation of area of burns. Surg Gynecol Obstet 1944; 79:352–361.Google Scholar
- 50.The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 2007; 120:1116–1122.Google Scholar
- 51.Moan J, Lagunova Z, Porojnicu AC. Vitamin D, photobiology and relevance for cancer. Sunlight, Vitamin D and Health, 2006:33–40. Proceedings of the meeting Sunlight, Vitamin D and Health House of Commons London.Google Scholar
- 52.Pagh Nielsen K, Porojnicu AC, Lagunova Z et al. Solarier og sol produserer D-vitamin, mens solkremer med høy beskyttelsesfaktor reduserer produksjonen kraftig. Submitted, 2006.Google Scholar